Starling Group

Starling Group is a family office based in the United Arab Emirates, established in 1986. The firm primarily engages in private equity investments, focusing on various strategies including leveraged buyouts, growth capital, and venture capital. Its investment approach encompasses limited partnership positions, targeting seed and early-stage companies, as well as late-stage ventures. By leveraging its expertise, Starling Group aims to support businesses at different stages of their development and contribute to their growth.

Sana Helal

Director-Investments

Ahmed Jamal Jawa

President, Chief Executive Officer, Vice Chairman, Board Member and Member of the Executive Committe

Tariq Rishi

Director- Investments

2 past transactions

Samumed, LLC

Series B in 2018
Samumed, LLC is engaged in small molecule drug development using assays and screens for the treatment of oncology and degenerative diseases. Its product includes SM04690, a small molecule inhibitor of the Wnt pathway that is administered as an intra-articular injection for treatment of osteoarthritis of the knee; and SM07883, a small-molecule designed to reduce disease pathology. The company was known as Wintherix & Epitherix, LLC. Samumed, LLC was founded in 2007 and is based in San Diego, California.

Samumed, LLC

Series A in 2013
Samumed, LLC is engaged in small molecule drug development using assays and screens for the treatment of oncology and degenerative diseases. Its product includes SM04690, a small molecule inhibitor of the Wnt pathway that is administered as an intra-articular injection for treatment of osteoarthritis of the knee; and SM07883, a small-molecule designed to reduce disease pathology. The company was known as Wintherix & Epitherix, LLC. Samumed, LLC was founded in 2007 and is based in San Diego, California.